The heaviest week of the season so far compresses most of its risk into one Wednesday night: Alphabet reports into a $180–190bn capex guide and a cloud backlog that has swelled to roughly $462bn, Tesla reports a quarter whose delivery number is already public, and IBM holds the call the market has waited for since a 14 July profit warning triggered the worst one-day drop in its century-plus listed history and left full-year guidance an open question. Thursday is nearly as loaded: Intel prints after sliding roughly a third from its late-June high on unconfirmed reports of 18A yield delays, and SAP reports just after the US close as the first big enterprise-software print since IBM’s warning knocked the whole group. Around the mega-caps, the week offers cleaner single-theme reads: GE Vernova on the power demand behind the AI buildout, hours before Alphabet frames the spending side of the same trade; Novartis opening the week Tuesday with pharma’s tariff deadline ten days out; Texas Instruments on the analog recovery; Santander on European banks after the ECB’s June rate increase; and TotalEnergies reporting a quarter it has already largely pre-disclosed.

πŸ‡ΊπŸ‡Έ Alphabet

~$4.2T · Wednesday 22-Jul

$GOOGL reports second-quarter results on Wednesday after the close – the event of the week. The first quarter set a demanding baseline: revenue up 22% to $109.9bn, Google Cloud up 63% to $20.0bn at a 33% operating margin, and capex more than doubled year on year to $35.7bn, with the full-year guide raised to $180–190bn and management flagging a further “significant increase” for 2027. The number that reframed the story sits in the filings: Google Cloud’s remaining performance obligations – contracted work not yet recognised as revenue – reached about $462bn at the end of March, nearly double the prior quarter, with more than half expected to convert within two years. Consensus sits around $2.86 of earnings on roughly $116–117bn of revenue, and the shares come in several percent off their mid-July high after a media report – not confirmed by the company – that the next Gemini model is running behind schedule.

Our readHow fast that backlog converts is the swing factor – Cloud growth near 60% with the $462bn book still building is what the market is paying for, and the conversion pace matters more than the headline beat. Watch the capex line – whether $180–190bn is reiterated or raised, and how firmly the 2027 increase gets framed – Search growth as antitrust-mandated choice screens and restrictions on default-search arrangements begin to take effect on phones and browsers, and free cash flow, which fell to about $10bn last quarter against $36bn of capex. The read-through is the widest of the week: Alphabet’s spending guide has become one of the market’s most important signals for the AI-capex complex – chip suppliers, networking, power – so a clean quarter underwrites the whole trade, while a wobble in Cloud conversion would land well beyond one stock.

πŸ‡ΊπŸ‡Έ Tesla

~$1.4T · Wednesday 22-Jul

$TSLA reports Wednesday after the close, sharing the night with Alphabet – and arrives with its headline number already public: 480,126 deliveries, announced on 2 July, up 25% year on year and Tesla’s best second quarter ever, though short of the all-time quarterly record. The market’s response was the tell: the shares fell about 7% that day anyway, on the view that volume leaned on price cuts and that, at this valuation, the story is graded on margins and autonomy rather than units. That puts the weight on automotive gross margin excluding regulatory credits – 19.2% last quarter, but flattered by one-time warranty and tariff items management itself flagged. Sell-side consensus compiled by the company sits near $27.6bn of revenue and $0.55 of adjusted earnings. On autonomy, the robotaxi service added Miami in early July – its first market outside Texas – though third-party trackers still put the unsupervised fleet in the low dozens, and Cybercab output is ramping slowly.

Our readAuto gross margin ex-credits is the swing factor – whether something near 19% survives a quarter of price cuts without the one-off benefits that helped last time. Watch the robotaxi and Cybercab cadence against a shareholder Q&A dominated by questions about missed timelines, the energy business after a 13.5 GWh deployment quarter, up 41% – deployments have not automatically converted into revenue – and any US demand commentary now the federal EV credit is gone. The read-across is about the tape as much as the stock: a delivery beat that sold off says beats on volume are not enough at these multiples – the bar every mega-cap reports under this week.

πŸ‡ΊπŸ‡Έ Intel

~$478B · Thursday 23-Jul

$INTC reports Thursday after the close – the highest-drama print of the week. The shares roughly quadrupled over the past year on the promise of the 18A manufacturing process, peaked at the end of June, then fell about 20% in a single week in early July on industry reports – never confirmed by the company – that 18A will not reach profitable yields until late 2026 or 2027; they now sit roughly a third below the high. The first quarter itself was solid – revenue up 7% to $13.6bn, adjusted earnings well ahead of a low bar, and 18A officially in high-volume manufacturing with management claiming yields “ahead of internal projections” – but the foundry arithmetic remains stark: a $2.4bn operating loss in the quarter against less than $200m of external foundry revenue. Guidance for this quarter calls for $13.8–14.8bn of revenue.

Our readThe 18A yield disclosure is the swing factor – this call is management’s first full opportunity to rebut or validate the delay reports, and with the shares still valued at around 100 times forward earnings on some estimates, there is little room between the two outcomes. Watch the Panther Lake ramp, any firm 14A customer commitment – two prospects are evaluating test chips, with decisions promised from the second half – and the foundry-loss trajectory against the promise of breakeven exiting 2027. The read-through covers the whole US-chipmaking trade: with the US government holding a 9.9% stake, this print doubles as a referendum on whether leading-edge manufacturing can ramp economically on American soil.

πŸ‡ΊπŸ‡Έ GE Vernova

~$284B · Wednesday 22-Jul

$GEV reports Wednesday before the open – the purest “who powers AI” print of the season, landing hours before Alphabet frames the spending side of the same trade. The first quarter ran hot: orders up 71% organically to $18.3bn, the gas-turbine backlog plus slot reservations reaching 100 GW, Electrification booking $2.4bn of data-centre equipment orders – more than in all of 2025 – and full-year guidance raised on revenue, margin and free cash flow. Consensus for the quarter sits around $3.1 of earnings, up roughly 70% year on year, and the demand backdrop keeps delivering datapoints: the mid-July PJM capacity auction cleared at its price cap at a record cost, with data centres cited by the market monitor as a major driver. The shares sit about 10% below their early-July record, still up over 60% this year on a demanding multiple.

Our readTurbine and grid orders are the swing factor – progress from 100 GW toward the 110 GW year-end ambition, and whether new slots keep pricing well above last year’s. Watch Electrification margins as the Prolec acquisition consolidates, and Wind, where the first quarter’s loss already consumed most of the roughly $400m full-year loss budget – the likeliest place for the guidance math to strain. The read-across runs both ways on Wednesday: hyperscaler capex guides are the demand signal and GE Vernova’s order book is the confirmation – though at this valuation, an in-line quarter without another raise could cool the whole power trade.

πŸ‡¨πŸ‡­ Novartis

~$284B · Tuesday 21-Jul

$NVS opens the week on Tuesday, reporting from Basel before the US open. The setup is unusually well-telegraphed: the first quarter missed slightly on core earnings as US generics cut Entresto sales nearly in half, and consensus for the quarter sits between roughly $2.15 and $2.25 of core earnings depending on the provider, while full-year guidance is generally expected to hold. The growth engine underneath is real: Kisqali up 55%, Pluvicto up 70% and Kesimpta up 26% last quarter, against the erosion in Entresto, Promacta and Tasigna. And the policy clock may matter more than the quarter: US tariffs on patented pharmaceuticals are scheduled to take effect on 31 July, ten days after this call, with Swiss-origin drugs capped at a 15% tier unless a company-specific agreement secures lower rates – and Novartis has said its own US agreement and expanding American manufacturing footprint, a $23bn commitment, should substantially mitigate its exposure.

Our readThe arithmetic between Entresto’s erosion and the growth brands is the swing factor – whether the portfolio keeps group sales growing through the steepest part of the generic cliff. Watch the guidance language – a held outlook on a soft quarter is the expected script, so any deviation in either direction becomes the story – and the tariff commentary, the first from big pharma this close to the effective date. The read-through goes first to Roche, reporting Thursday from the same Swiss tariff tier, then to the AstraZeneca, GSK and Sanofi prints the following week.

Get weekly earnings previews

Join the waitlist for early access to FinRyse – and receive our weekly market briefings.

πŸ‡ΊπŸ‡Έ IBM

~$200B · Wednesday 22-Jul

$IBM’s Wednesday-night call is a post-mortem: the numbers are largely already out. On 14 July the company pre-announced preliminary second-quarter results – revenue of $17.2bn, up just 1%, and operating EPS of $2.93, both short of expectations – and the stock fell roughly 25%, its worst single day in more than a century as a listed company. Management’s explanation had three layers: clients redirected late-June capex toward servers, storage and memory to get ahead of AI-driven price rises in supply-constrained hardware; industry-wide cybersecurity concerns distracted buyers; and – in the company’s own words – “this quarter we faltered”, with numerous large deals slipping past quarter-end. What the pre-announcement conspicuously left open was full-year guidance, deferred to this call.

Our readThe full-year guide is the swing factor – whether the 5%-plus constant-currency revenue-growth and roughly $15.7bn free-cash-flow frame survives, and whether the slipped deals are described as closing in the third quarter or quietly gone. Watch Software, where 5% growth sits well below the 10%-plus ambition even with Red Hat accelerating, and how management now frames an AI infrastructure buildout it said redirected client spending toward servers, storage and memory – and away from parts of IBM’s software and mainframe portfolio. The wider stakes are the reason to listen: the warning hit Accenture, ServiceNow, Salesforce and SAP the same day, and this call is the first real evidence on whether that was contagion or overreaction – with SAP’s own print landing 24 hours later.

πŸ‡ΊπŸ‡Έ Texas Instruments

~$259B · Wednesday 22-Jul

$TXN reports Wednesday after the close – the broadest single read on the industrial economy in the chip calendar. The recovery has been emphatic: first-quarter revenue rose 19%, with industrial up more than 30% year on year – growth management called broad across regions and sectors – automotive flat near its prior peak with China auto still falling, and data-centre demand described as nearly doubling. Guidance for this quarter is $5.0–5.4bn, with consensus near the midpoint at about $1.91 of earnings, and the stock is priced for the cycle to keep delivering: up around 60% this year at roughly 34 times forward earnings, even after fading with the semis tape in mid-July.

Our readThe third-quarter guide is the swing factor – at this multiple the market needs above-seasonal momentum to continue, and TI’s short lead times make its guide one of the clearest near-term cyclical signals in chips. Watch whether automotive finally turns, how much of the industrial strength management attributes to restocking versus end demand, and the gross-margin path as depreciation from the fab buildout steps up. As the first of the big analog names to report – NXP, ON Semiconductor and Microchip follow over the next fortnight – the end-market colour will move the group as much as the numbers.

πŸ‡ͺπŸ‡Έ Banco Santander

~$193B · Wednesday 22-Jul

$SAN reports first-half results Wednesday morning in Madrid – the biggest European bank print of the week, a day before the ECB meets. The backdrop has inverted since spring: the ECB raised rates in June, its first move since the easing cycle ended, turning the net-interest-income question from how fast it erodes to when it inflects. Santander enters from a record first quarter – underlying profit of €3.56bn, up 12%, on a 15.2% return on tangible equity – with a 14.4% CET1 ratio well above the 12.8–13% year-end target, though the acquisitions will absorb much of that headroom: TSB, consolidating for the first time this quarter, is expected to consume roughly 60 basis points of capital, and the $12.2bn Webster deal in the US, still awaiting final approvals, roughly 150. The ADR touched an all-time high in early July, up roughly 60% in a year, as European banks became one of the year’s strongest trades.

Our readThe net-interest-income trajectory under a turned rate cycle is the swing factor – whether management frames June’s hike as a margin tailwind arriving for its Spanish and Portuguese deposit base. Watch credit quality in Brazil and Argentina, where cost of risk runs far above group levels, TSB’s first consolidated quarter against the promised capital glidepath, and the buyback cadence with the current programme roughly three-quarters executed. Reporting a day ahead of the ECB and a week ahead of BBVA and Lloyds, Santander frames the European bank season that follows it.

πŸ‡©πŸ‡ͺ SAP

~$184B · Thursday 23-Jul

$SAP reports Thursday evening European time – just after the US close – as Europe’s biggest software company and, since 14 July, the market’s designated test of whether IBM’s warning generalises. The stock supplies its own drama: it trades near 52-week lows, down nearly half from its high, on doubts that AI agents can be monetised in ERP software as fast as the multiple once assumed – and the company has reportedly restricted most non-AI hiring and tightened travel and supplier spending this month to redirect resources toward its AI push. The first quarter was better than the tape implies: cloud revenue up 27% in constant currencies and the current cloud backlog – the forward-demand gauge – up 25%, though management said first-quarter growth benefited from quarter-specific effects, setting up a tougher comparison, and the strong euro drags on every reported number.

Our readCurrent cloud backlog growth is the swing factor – hold near 25% in constant currencies and the IBM read-through starts to look idiosyncratic; crack, and the software derating has its evidence. Watch cloud revenue against the full-year €25.8–26.2bn constant-currency guide, any quantified proof points on Business AI adoption, and margins in light of the spending discipline now funding the AI push. With the enterprise-software group still marked down from the 14 July selloff, this print carries more read-across weight than a SAP quarter usually does.

πŸ‡«πŸ‡· TotalEnergies

~$179B · Thursday 23-Jul

$TTE reports Thursday morning, Paris time – and, unusually, most of the surprise is already gone. Pre-quarter indicators published on 16 July sketched the shape of it: Brent averaged $103.8 a barrel over the quarter on the Middle East conflict premium, European refining margins jumped, and downstream results and oil trading were flagged sharply higher – while the one negative, a “significant” decline in Integrated LNG on weak gas trading, was disclosed but not sized. Production ran near 2.4m barrels of oil equivalent a day, with the conflict’s hit to output smaller than guided in April, the buyback was authorised at the top of its $0.75–1.5bn quarterly range, and the balance sheet was flagged as improving.

Our readThe size of the LNG trading shortfall is the swing factor – the one number the pre-release left open, and the more notable because it points the opposite way to Shell, whose own update guided gas trading significantly higher; that divergence reads as positioning rather than market. Watch the third-quarter buyback authorisation – the $0.75–1.5bn framework was calibrated to $60–70 Brent and spot has settled back into the mid-$80s after the spike – and the gearing improvement that underwrites the payout. With refining strength pre-flagged by TotalEnergies, Shell and BP alike, the reports over the next fortnight are mostly about who converts the windfall into distributions.

Weekly Calendar

Some notable names reporting this week:

Company Country Sector Timing
Tuesday 21-Jul
Novartis πŸ‡¨πŸ‡­ Pharma BMO
Wednesday 22-Jul
Alphabet πŸ‡ΊπŸ‡Έ Search / cloud / AI AMC
Tesla πŸ‡ΊπŸ‡Έ EVs / energy AMC
Philip Morris International πŸ‡ΊπŸ‡Έ Tobacco / nicotine BMO
GE Vernova πŸ‡ΊπŸ‡Έ Power equipment BMO
Texas Instruments πŸ‡ΊπŸ‡Έ Semiconductors (analog) AMC
IBM πŸ‡ΊπŸ‡Έ Software / IT services AMC
Banco Santander πŸ‡ͺπŸ‡Έ Banking BMO
Thursday 23-Jul
Intel πŸ‡ΊπŸ‡Έ Semiconductors AMC
Roche πŸ‡¨πŸ‡­ Pharma / diagnostics BMO
Nestlé πŸ‡¨πŸ‡­ Food & beverages BMO
RTX πŸ‡ΊπŸ‡Έ Aerospace & defence BMO
T-Mobile US πŸ‡ΊπŸ‡Έ Telecom BMO
Thermo Fisher Scientific πŸ‡ΊπŸ‡Έ Life-sciences tools BMO
SAP πŸ‡©πŸ‡ͺ Enterprise software AMC
TotalEnergies πŸ‡«πŸ‡· Oil & gas BMO
Union Pacific πŸ‡ΊπŸ‡Έ Railroads BMO
Friday 24-Jul
American Express πŸ‡ΊπŸ‡Έ Payments / consumer finance BMO
CATL (expected) πŸ‡¨πŸ‡³ Batteries
NextEra Energy πŸ‡ΊπŸ‡Έ Utilities / renewables BMO
Verizon πŸ‡ΊπŸ‡Έ Telecom BMO